Intratumoural interleukin-2 therapy can induce regression of non-resectable mastocytoma in dogs.

Aim: Mast cell tumours (MCT) are common skin tumours in dogs. If complete surgical removal of the tumours is not possible, then another therapy is needed. In the current study we tested the therapeutic effect of intratumoural injection of interleukin-2 (IL-2).

All-cause in-hospital mortality and comorbidity in diabetic and non-diabetic patients with stroke.

Introduction: The aim of this study was to compare diabetic and non-diabetic patients with stroke with regard to their all-cause in-hospital mortality and possible differences regarding their comorbidities.

Methods: All patients of the Munich Stroke Registry (2003-2004, n=537) were assessed. Hospital mortality in diabetic (n=160, 29.

Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.

Aims/hypothesis: The primary aim of this study was to compare the results of HbA(1c) measurements with those of an OGTT for early diagnosis of 'silent diabetes' in patients with coronary artery disease (CAD) undergoing angiography without prediagnosed diabetes. A secondary aim was to investigate the correlation between the extent of CAD and the glycaemic status of the patient.

Methods: Data from 1,015 patients admitted for acute (n = 149) or elective (n = 866) coronary angiography were analysed.

The Munich Myocardial Infarction Registry: impact of C-reactive protein and kidney function on hospital mortality in diabetic patients.

Introduction: The aim of this study was to analyse hospital mortality with regards to the presence of diabetes, elevation of C-reactive protein (CRP) levels and impaired kidney function (IKF) on admission.

Methods: All patients in the Munich Myocardial Infarction Registry (1999-2004, n = 2,015) were assessed. In both the diabetic (n = 770, 38%) and non-diabetic (n = 1,245, 61.